Global Research Services, LLC

GRS is a privately held clinical research organization (CRO) providing services to pharmaceutical, biotechnology and medical device companies for the efficient clinical development of new compounds and devices with a specialty in cardiovascular, renal, metabolic and rheumatic disease therapeutic areas.

Headquartered in Rockville, Maryland, GRS maintains subsidiary offices in Canada, Germany, Poland, China, and India. In partnership with the leading cardiovascular CRO in Latin America, ECLA (Estudios Clínicas Latinoamérica), GRS maintains a presence in Argentina and Brazil. GRS provides research capabilities in the pivotal emerging markets that are in greatest demand by our clients.

GRS offers performance, experienced staff, demonstrated therapeutic area expertise, global site networks, effective management plans, premier capabilities, advanced communication technologies and a full-range of services. These services include strategic study design, protocol development, site selection and start up, project management, site management, targeted monitoring, comprehensive data management, biostatistics, regulatory support, quality assurance, medical writing, global pharmacovigilance and investigator relationship management technologies.

GRS differentiates its service offerings from its competitors by focusing its expertise on cardiovascular, renal, metabolic and rheumatic disease drugs and devices. This focus provides value-driven clinical development strategies and services with superior project management, 24/7 worldwide coverage of safety events, 21CFR 11 compliant data management, and integrated communications for increased value to our clients.

Corporate Headquarters
2101 Gaither Rd. Suite 450 Rockville, MD 20850 USA